MRI and diffusion-weighted MRI volumetry for identification of complete tumor responders after preoperative chemoradiotherapy in patients with rectal cancer: A bi-institutional validation study

Annals of Surgery

Volumn 262, Issue 6, 2015, Pages 1034-1039

  Lambregts, Doenja M J ^a,b   Rao, Sheng Xiang ^a,c   Sassen, Sander ^d   Martens, Milou H ^a,b   Heijnen, Luc A ^a,b   Buijsen, Jeroen ^a,b   Sosef, Meindert ^d   Beets, Geerard L ^a,b   Vliegen, Roy A ^d   Beets Tan, Regina G H ^a,b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c FUDAN UNIVERSITY   (China)

^d Zuyderland Medical Centre   (Netherlands)

Author keywords

Chemoradiotherapy; Complete response; Diffusion weighted MR imaging; MRI; Rectal cancer; Tumor volumetry

Indexed keywords

RAPAMYCIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CHEMORADIOTHERAPY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFUSION WEIGHTED IMAGING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RECTUM CANCER; SENSITIVITY AND SPECIFICITY; TREATMENT RESPONSE; TUMOR VOLUME; VALIDATION STUDY; VOLUMETRY; ADENOCARCINOMA; ADJUVANT CHEMORADIOTHERAPY; ADJUVANT THERAPY; CANCER STAGING; CLINICAL TRIAL; COMPARATIVE STUDY; FOLLOW UP; MIDDLE AGED; PATHOLOGY; PROCEDURES; PROSPECTIVE STUDY; RECTAL NEOPLASMS; RECTUM; REMISSION; SURGERY; TREATMENT OUTCOME; VERY ELDERLY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CHEMORADIOTHERAPY, ADJUVANT; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PROSPECTIVE STUDIES; RECTAL NEOPLASMS; RECTUM; REMISSION INDUCTION; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 84946801359     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000000909     Document Type: Article

References (22)

1. Maas M, Beets-Tan RG, Lambregts DM, et al. Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. J Clin Oncol. 2011;29:4633-4640.
2. Habr-Gama A, Perez RO, Proscurshim I, et al. Patterns of failure and survival for nonoperative treatment of stage c0 distal rectal cancer following neo-adjuvant chemoradiation therapy. J Gastrointest Surg. 2006;10:1319-1328; discussion 1328-1329.
3. Curvo-Semedo L, Lambregts DM, Maas M, et al. Rectal cancer: assessment of complete response to preoperative combined radiation therapy with chemotherapy-conventional MR volumetry versus diffusion-weighted MR imaging. Radiology. 2011;260:734-743.
4. Kim SH, Lee JM, Hong SH, et al. Locally advanced rectal cancer: added value of diffusion-weighted MR imaging in the evaluation of tumor response to neoadjuvant chemo-and radiation therapy. Radiology. 2009;253:116-125.
5. Lambregts DM, Vandecaveye V, Barbaro B, et al. Diffusion-weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter study. Ann Surg Oncol. 2011;18:2224-2231.
6. Song I, Kim SH, Lee SJ, et al. Value of diffusion-weighted imaging in the detection of viable tumor after neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer: comparison with T2-weighted and PET/CT imaging. Br J Radiol. 2012;85:577-586.
7. Ha HI, Kim AY, Yu CS, et al. Locally advanced rectal cancer: diffusion-weighted MR tumor volumetry and the apparent diffusion coefficient for evaluating complete remission after preoperative chemoradiation therapy. Eur Radiol. 2013;23:3345-3353.
8. Carbone SF, Pirtoli L, Ricci V, et al. Assessment of response to chemoradiation therapy in rectal cancer using MR volumetry based on diffusion-weighted data sets: a preliminary report. Radiol Med. 2012;117:1112-1124.
9. Buijsen J, Lammering G, Jansen RL, et al. Phase I trial of the combination of the Akt inhibitor nelfinavir and chemoradiation for locally advanced rectal cancer. Radiother Oncol. 2013;107:184-188.
10. Rodel C, Trojan J, Bechstein WO, et al. Neoadjuvant short-or long-term radio(chemo)therapy for rectal cancer: how and who should be treated? Dig Dis. 2012;30(suppl 2):102-108.
11. Radu C, Berglund A, Pahlman L, et al. Short-course preoperative radiotherapy with delayed surgery in rectal cancer-a retrospective study. Radiother Oncol. 2008;87:343-349.
12. Hatfield P, Hingorani M, Radhakrishna G, et al. Short-course radiotherapy, with elective delay prior to surgery, in patients with unresectable rectal cancer who have poor performance status or significant co-morbidity. Radiother Oncol. 2009;92:210-214.
13. Vliegen RF, Beets GL, Lammering G, et al. Mesorectal fascia invasion after neoadjuvant chemotherapy and radiation therapy for locally advanced rectal cancer: accuracy of MR imaging for prediction. Radiology. 2008;246:454-462.
14. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonpara-metric approach. Biometrics. 1988;44:837-845.
15. Torkzad MR, Lindholm J, Martling A, et al. MRI after preoperative radiotherapy for rectal cancer; correlation with histopathology and the role of volumetry. Eur Radiol. 2007;17:1566-1573.
16. Buijsen J, van den Bogaard J, Janssen MH, et al. FDG-PET provides the best correlation with the tumor specimen compared to MRI and CTin rectal cancer. Radiother Oncol. 2011;98:270-276.
17. Lambregts DM, Beets GL, Maas M, et al. Tumour ADC measurements in rectal cancer: effect of ROI methods on ADC values and interobserver variability. Eur Radiol. 2011;21:2567-2574.
18. Kim YC, Lim JS, Keum KC, et al. Comparison of diffusion-weighted MRI and MR volumetry in the evaluation of early treatment outcomes after preoperative chemoradiotherapy for locally advanced rectal cancer. J Magn Reson Imaging. 2011;34:570-576.
19. Baron P, Dorrius MD, Kappert P, et al. Diffusion-weighted imaging of normal fibroglandular breast tissue: influence of microperfusion and fat suppression technique onthe apparent diffusion coefficient.NMR Biomed. 2010;23:399-405.
20. Intven M, Reerink O, Philippens ME. Repeatability of diffusion-weighted imaging in rectal cancer. J Magn Reson Imaging. 2014;40:146-150.
21. Lahaye MJ, Beets GL, Engelen SM, et al. Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy. Part II. What are the criteria to predict involved lymph nodes? Radiology. 2009;252:81-91.
22. Suppiah A, Hunter IA, Cowley J, et al. Magnetic resonance imaging accuracy in assessing tumor down-staging following chemoradiation in rectal cancer. Colorectal Dis. 2009;11:249-253.